Celyad CEO Filippo Petti On In-House Allogeneic Cell Therapy Manufacturing
Source: Bioprocess Online
Join Matt Pillar and Erin Harris as we catch up with Celyad Oncology chief Filippo Petti on his company's differentiated approach to the discovery and development of allogeneic CAR-T cell therapy candidates for the treatment of cancer. Petti shares the technology and how the company intends to scale in-house manufacturing in its Belgium-based manufacturing facility.
This website uses cookies to ensure you get the best experience on our website. Learn more